177Lu-DOTA-EB-TATE Trial for Metastatic Hurthle-Cell Thyroid Cancer Initiated
A clinical trial is underway to evaluate 177Lu-DOTA-EB-TATE in adult patients with metastatic Hurthle-cell thyroid cancer.
Therapeutic Area
Therapeutic area intelligence for Radioactive Drug Therapy with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.